EUVIMEDEUVIMED entdecken
Crossref

Lipopolysaccharide-binding protein functions as factor VIII inhibitor in bullous pemphigoid associated with acquired hemophilia A

Senlin Ma, Yuxin Sun, Wenzhen Zhou, Yinuo Yuan, Yifan Yang, Yanchao Zheng, Qiuxin Lu, Qingjiang Chen, Mingyue Ding, Guoyan Wang, Mingquan Chen

Archives of Dermatological Research · 2025

DOI: 10.1007/s00403-025-04078-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Senlin Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Hemophilia A, Factor VIII, Carrier Proteins. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bullous pemphigoid (BP) represents an autoimmune blistering disorder that may coexist with acquired hemophilia A (AHA), a rare autoimmune condition arising from the formation of circulating autoantibodies directed against factor VIII (FVIII). The underlying pathomechanisms of BP-AHA remain elusive. This study conducted a retrospective analysis of data from 196 BP patients admitted to our hospital. We have collected serum samples from a recently admitted BP-AHA patient and healthy controls to isolate, screen and identify the potential FVIII inhibitors. The expression and function of lipopolysaccharide-binding protein (LBP) in BP-AHA were further validated by a series of biochemical experiments. The retrospective analysis showed that the activated partial thromboplastin time (APTT) values of seven patients exceeded 33.8 s (normal value) in 196 BP patients. FVIII: C (%) and FVIII inhibitors in the plasma of partial prolonged-APTT patients were significantly altered compared with control group or non-prolonged-APTT group. LBP was identified as a potential inhibitory protein of FVIII. Consistently, a notable alteration in LBP expression was observed in the plasma of BP patients with prolonged-APTT. Moreover, the amount of LBP bound to FVIII in the BP-AHA patient was notably higher than that in control group, which was also markedly reversed after treatment. In vitro experiments finally confirmed that exogenous LBP directly bound to FVIII and significantly inhibited FVIII activity. In conclusion, the incidence of AHA in BP patients may be substantially underestimated, which needs more vigilance towards indicators such as APTT, LBP, and FVIII. LBP emerges as an inhibitory protein of FVIII, indicating the potential involvement in the progression of BP-AHA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pemphigoid, BullousHemophilia AFactor VIIICarrier ProteinsMembrane GlycoproteinsAcute-Phase ProteinsHumansMaleRetrospective StudiesFemaleAgedAutoantibodiesMiddle AgedAged, 80 and overAdultPartial Thromboplastin TimeLipopolysaccharide-Binding Protein

Stichwörter der Autor:innen

Acquired hemophilia ABullous pemphigoidFactor VIIILipopolysaccharide-binding protein

Substanzen

Factor VIIICarrier ProteinsAutoantibodiesMembrane GlycoproteinsAcute-Phase ProteinsLipopolysaccharide-Binding Protein

Autor:innen und Institutionen

  • Department of Emergency, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
  • Sheyang County People's Hospital, No.129 Xingfu Avenue, Hede Town, Sheyang County, Yancheng City, Jiangsu Province, 224399, China.
  • Municipal Hospital of Chifeng, 1 Middle Section of Zhaowuda Road, Chifeng, Inner Mongolia Autonomous Region, 024099, China.
  • Department of Emergency, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China. chenmingquan_art@163.com.

Zitieren

APA

Ma, S., Sun, Y., Zhou, W., Yuan, Y., Yang, Y., Zheng, Y., Lu, Q., Chen, Q., Ding, M., Wang, G., & Chen, M. (2025). Lipopolysaccharide-binding protein functions as factor VIII inhibitor in bullous pemphigoid associated with acquired hemophilia A. Archives of Dermatological Research. https://doi.org/10.1007/s00403-025-04078-1

Vancouver

Ma S, Sun Y, Zhou W, Yuan Y, Yang Y, Zheng Y, et al. Lipopolysaccharide-binding protein functions as factor VIII inhibitor in bullous pemphigoid associated with acquired hemophilia A. Archives of Dermatological Research. 2025. doi:10.1007/s00403-025-04078-1

BibTeX
@article{Ma2025,
  author = {Ma, Senlin and Sun, Yuxin and Zhou, Wenzhen and Yuan, Yinuo and Yang, Yifan and Zheng, Yanchao and Lu, Qiuxin and Chen, Qingjiang and Ding, Mingyue and Wang, Guoyan and Chen, Mingquan},
  title = {Lipopolysaccharide-binding protein functions as factor VIII inhibitor in bullous pemphigoid associated with acquired hemophilia A},
  journal = {Archives of Dermatological Research},
  year = {2025},
  doi = {10.1007/s00403-025-04078-1}
}
Kostenlos starten →